NCT07412457Not yet recruiting
Guideline Adherence in Dyslipidemia With Clinical Decision Support
Assessment of Adherence to Clinical Practice Guidelines in Patients With Dyslipidemia Using a Clinical Decision Support System
Source: ClinicalTrials.gov · Last updated 24 Feb 2026
Brief summary (registry, in English)
Objective: To validate the performance of the developed clinical decision support system (CDSS) for participants with lipid metabolism disorders based on a decision tree algorithm. Materials and Methods: A clinical decision support system for participants with lipid profile abnormalities will be developed using the Orbeon open-source online form creation platform based on current clinical guidelines. During the CDSS pilot implementation, the electronic medical records (EMRs) of 500 participants from the Institute of Personalized Cardiology of the Biomedical Science and Technology Park at Sechenov University will be analyzed. Retrospective data on prescribed lipid-lowering therapy extracted from the EHR will be compared with the CDSS recommendations. The accuracy of the decisions will be assessed by three independent experts based on digitized clinical and laboratory patient profiles. The primary endpoint of the study will be to determine the accuracy of the system. Results: This study will result in the development (creation) and pilot application of the CDSS program in participants with dyslipidemia in real clinical practice. Conclusion: The developed CDSS system for dyslipidemia will significantly reduce the time required for clinical decision-making and help avoid errors in the interpretation of patient data.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 9 Feb 2026
- Start date
- 1 Apr 2026
- Primary completion date
- 30 Apr 2027
- Lead sponsor
- I.M. Sechenov First Moscow State Medical University
- Diseases
- Coronary artery disease
- NCT number
- NCT07412457
What you commit to
- Study type: Observational
- Planned participants: 500
- From 1 Apr 2026 to the primary completion date, 30 Apr 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Absence of a consensus opinion on the clinical case among two of the three experts.
Who the study is looking for
- Availability of the required amount of patient data for completion of the questionnaire-based system;
- Age 18 years or older;
- Signed informed consent to participate in the study.
- Non-inclusion criteria:
- Patients with insufficient data to complete the questionnaire;
- Refusal to sign informed consent for participation in the study.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| 1 University Hospital Coordinator of this site? Confirm its status | Moscow | Russia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.